Earkart Limited Completes U.S. FDA Registration, Expands Hearing Aid Market Access
Earkart Limited, an Indian hearing healthcare technology company, has completed its U.S. FDA establishment registration and secured active medical device listings across four hearing aid categories, including prescription and over-the-counter devices. This milestone supports the company's plans to enter the U.S. market through partnerships and distribution, leveraging its indigenous manufacturing capabilities. Market projections estimate significant growth in the U.S. hearing aids sector by 2035. Earkart noted that registration does not equate to FDA approval for individual products.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (70/100). Lens Score 36/100.
Outlets measured: moneycontrol, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (65–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 18 Nov, 12:43 pm. Other outlets followed.
